Tibet Rhodiola Pharmaceutical Holding Co. (SHA:600211)
40.37
-0.46 (-1.13%)
Nov 6, 2026, 3:00 PM CST
| Market Cap | 12.85B -11.0% |
| Revenue (ttm) | 3.07B +12.8% |
| Net Income | 991.91M +1.1% |
| EPS | 3.08 +1.3% |
| Shares Out | 318.32M |
| PE Ratio | 13.11 |
| Forward PE | n/a |
| Dividend | 1.76 (4.35%) |
| Ex-Dividend Date | Sep 15, 2026 |
| Volume | 4,099,757 |
| Open | 40.10 |
| Previous Close | 40.83 |
| Day's Range | 40.06 - 41.18 |
| 52-Week Range | 34.80 - 48.99 |
| Beta | 0.24 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 31, 2026 |